Assessment of a New ECG-Based Score to Detect Left Heart Dysfunction in Adults with High Blood Pressure A Study Using Echocardiography to Validate the MVP Score

What this Trial Is About

Researchers are evaluating a new Morphology-Voltage-P-wave Score MVP Score to help diagnose left ventricular diastolic dysfunction in people with hypertension. This observational study collects detailed data including demographics, clinical signs, laboratory tests, and heart ultrasound echocardiography results to validate the usefulness of the MVP Score in identifying heart dysfunction related to high blood pressure. Participants will have their 12-lead electrocardiogram ECG reviewed to calculate the MVP Score, which will then be compared with results from transthoracic echocardiography assessing heart function. The study groups include patients with and without left ventricular diastolic dysfunction, based on these assessments. During the study, investigators will gather information from medical records and perform ECG and echocardiography evaluations. They will analyze the data using statistical software to confirm the MVP Scores accuracy in diagnosing diastolic dysfunction. The main outcome measured is the presence of diastolic dysfunction within one week of assessment. Participation involves one-time diagnostic tests and data collection with no treatment interventions.

Validation and Assessment of Novel Morphology-Voltage-P-wave Score for Diagnosing Left Ventricular Diastolic Dysfunction in Patients With Hypertension